IQVIA Holdings Inc. (IQV)
148.99 USD -4.30 (-2.81%) Volume: 1.68M
IQVIA Holdings Inc.’s stock price stands at 148.99 USD, experiencing a drop of -2.81% this trading session with a trading volume of 1.68M, reflecting a year-to-date percentage change of -24.18%.
Latest developments on IQVIA Holdings Inc.
Today, IQVIA Holdings Inc. (NYSE:IQV) stock price movements were influenced by a series of key events. The company’s Q1 2025 earnings report showcased strong performance, leading to a buy rating despite industry challenges. With increased revenue guidance and strategic advancements, IQVIA displayed resilience and growth prospects. However, mixed sentiment was noted during the earnings call, amidst R&D challenges and valuation opportunities. Additionally, Barclays and UBS adjusted their price targets for IQVIA, reflecting demand concerns. CFO Ron Bruehlman is set to speak at the Bank of America Annual Health Care Conference on May 13, further supporting steady optimism for IQVIA Holdings.
A look at IQVIA Holdings Inc. Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
IQVIA Holdings Inc. has received a mixed bag of Smart Scores, with a high score in Growth indicating a positive long-term outlook for the company. With a strong focus on technology solutions and contract research services, IQVIA Holdings is well-positioned to capitalize on the growing demand for clinical development strategies and predictive analytics in the consumer health, biopharma, and medical technology industries. Despite a lower score in Dividend, the company’s resilience and momentum scores suggest a steady performance in the market.
Overall, IQVIA Holdings Inc. shows promise for future growth and success, with its high score in Growth reflecting its potential to expand and innovate within the healthcare industry. While the company may not be a top pick for dividend investors, its value, resilience, and momentum scores indicate a solid foundation for long-term success. With a focus on technology solutions and a global presence, IQVIA Holdings is well-equipped to navigate challenges and capitalize on opportunities in the evolving healthcare landscape.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
